Clinical Trial Update: 99mTc-rhAnnexin V-128 Imaging and Cardiotoxicity in Patients With Early Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating 99mTc-rhAnnexin V-128 imaging for cardiotoxicity in early breast cancer patients treated with doxorubicin; study terminated with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Doxorubicin-induced Cardiomyopathy

Snippet

Sponsor: Advanced Accelerator Applications | Conditions: Breast Cancer, Doxorubicin Induced Cardiomyopathy | Phase 2 | Status: TERMINATED | Results posted: 2020-12-11